Showing results (101-110 of 186) with videos related to
Sort By:
Pageof 19
Intensive Care Medicine|June 3, 2006
Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shockGuillaume Monneret, Alain Lepape, Nicolas Voirin, et al.Immunology Letters|August 30, 2016
Identification of CD177 as the most dysregulated parameter in a microarray study of purified neutrophils from septic shock patientsJulie Demaret, Fabienne Venet, Jonathan Plassais, et al.Journal of Immunological Methods|December 3, 2014
Flow cytometric evaluation of lymphocyte transformation test based on 5-ethynyl-2'deoxyuridine incorporation as a clinical alternative to tritiated thymidine uptake measurementFanny Poujol, Guillaume Monneret, Arnaud Friggeri, et al.Journal of the International AIDS Society|November 15, 2014
Relationship between discordant response to HAART, Tregs, immune activation and low-level viraemiaJulien Saison, Tristan Ferry, Julie Demaret, et al.Critical Care (London, England)|June 10, 2026
Monitoring T-cell function in septic shock: one-year experience with a fully automated assayThomas Lafon, Morgane Gossez, Annabelle Schild, et al.Intensive Care Medicine|October 24, 2008
Increased circulating regulatory T cells (CD4(+)CD25 (+)CD127 (-)) contribute to lymphocyte anergy in septic shock patientsFabienne Venet, Chun-Shiang Chung, Hakim Kherouf, et al.Intensive Care Medicine|July 10, 2013
Increased MerTK expression in circulating innate immune cells of patients with septic shockCaroline Guignant, Fabienne Venet, Séverine Planel, et al.Critical Care (London, England)|December 11, 2013
Decreased HLA-DR antigen-associated invariant chain (CD74) mRNA expression predicts mortality after septic shockMarie-Angélique Cazalis, Arnaud Friggeri, Laura Cavé, et al.Critical Care (London, England)|April 19, 2019
TCR activation mimics CD127<sup>low</sup>PD-1<sup>high</sup> phenotype and functional alterations of T lymphocytes from septic shock patientsJulie Mouillaux, Camille Allam, Morgane Gossez, et al.Journal of Critical Care|June 2, 2023
Granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients presenting sepsis-induced immunosuppression: The GRID randomized controlled trialCharles-Hervé Vacheron, Alain Lepape, Fabienne Venet, et al.Pageof 19